Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | OGA | O60502 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11937054 | 1.00 | CYP2C9 (0.30) | CYP2C9CYP2C19OGA | |
| SCHEMBL10045291 | 0.84 | — | — | |
| SCHEMBL10357880 | 0.82 | — | — | |
| SCHEMBL10045290 | 0.82 | — | — | |
| SCHEMBL11934549 | 0.82 | — | — | |
| SCHEMBL12154036 | 0.82 | — | — | |
| SCHEMBL403204 | 0.82 | — | — | |
| SCHEMBL24943576 | 0.78 | OGA (0.41) | CYP2C9CYP2C19OGA | |
| SCHEMBL10023957 | 0.78 | OGA (0.41) | CYP2C9CYP2C19OGA | |
| SCHEMBL12902089 | 0.78 | OGA (0.41) | CYP2C9CYP2C19OGA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160310521-A1 | POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS | SANOFI (FR) | 2016-10-27 | — | — | US | disclosed |
| US-8501711-B2 | Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent | SANOFI (FR) | 2013-08-06 | — | — | US | disclosed |
| US-20120108541-A1 | ACYLATED 1,6-ANHYDRO DECASACCHARIDE AND ITS USE AS AN ANTITHROMBOTIC AGENT | SANOFI (FR) | 2012-05-03 | — | — | US | disclosed |
| US-20120065153-A1 | AZASUGAR DERIVATIVES, HEPARANASE INHIBITORS, METHOD FOR PREPARING SAME, COMPOSITIONS CONTAINING SAME, USE THEREOF | SANOFI-AVENTIS (FR) | 2012-03-15 | — | — | US | disclosed |
| US-20070270354-A1 | Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof | SANOFI-AVENTIS (FR) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160310521-A1 | POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS | SERPINC1, F13B, F12 | CYP2C9 1313/4885CYP2C19 2463/4885OGA 1139/4885 |
| US-20120065153-A1 | AZASUGAR DERIVATIVES, HEPARANASE INHIBITORS, METHOD FOR PREPARING SAME, COMPOSITIONS CONTAINING SAME, USE THEREOF | HPSE, HAAO, HEXD | CYP2C9 307/4885CYP2C19 721/4885OGA 76/4885 |
| US-20070270354-A1 | Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof | HPSE, HAAO, HEXD | CYP2C9 298/4885CYP2C19 695/4885OGA 68/4885 |
| US-20120108541-A1 | ACYLATED 1,6-ANHYDRO DECASACCHARIDE AND ITS USE AS AN ANTITHROMBOTIC AGENT | FUT6, FUT5, CSGALNACT1 | CYP2C9 614/4885CYP2C19 816/4885OGA 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.